Multiple generics doesnt spell disaster, or does it. The banks,...

Multiple generics doesnt spell disaster, or does it. The banks, mining companies etc coexist quite profitably.

IF this thing gets to market, maybe a slight price ajustment might take place but everybdy is about meking money. Seems to me that GSK are S==ting themselves that thier market share might fall greater than they anticipated with RDY/Acl fonda!!(remember how upbeat RDY is for this product)

Very smart to release an announcement stating that you are introducing a product which is about to superceed one of your most profitable drugs, especially at a time like this!

Profit will not fall 50% as someone stated IMO, what would be the point of everyone going to the hassle to make something for nothing. If there was 10 competitors makbe the stakes would be different.